Helicobacter pylori and gastric mucosa-associated lymphoid tissue (MALT) lymphoma: Updated review of clinical outcomes and the molecular pathogenesis

Gut and Liver

Volumn 3, Issue 2, 2009, Pages 81-87

  Suzuki, Hidekazu ^a   Saito, Yoshimasa ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

API2 MALT1 fusion; BCL10; CD20; Eradication; Helicobacter pylori

Indexed keywords

ANTIBIOTIC AGENT; PROTEIN BCL 10; RITUXIMAB;

CANCER REGRESSION; DISEASE ASSOCIATION; ERADICATION THERAPY; GASTRECTOMY; GASTRITIS; GENE EXPRESSION PROFILING; HELICOBACTER HEILMANNII; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; REVIEW; STOMACH CARCINOGENESIS; STOMACH LYMPHOMA; SYSTEMATIC REVIEW; TREATMENT PLANNING;

EID: 67649289709     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2009.3.2.81     Document Type: Review

References (38)

1. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007;42:1-15.
2. Stolte M, Eidt S. Healing gastric MALT lymphomas by eradicating H. pylori? Lancet 1993;342:568. (Pubitemid 23259228)
3. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577. (Pubitemid 23259233)
4. Yi ZH, Ouyang Q, Li GD, Chen DY. Combined histology and molecular biology for diagnosis of early stage gastric MALT lymphoma. Chin J Dig Dis 2006;7:12-18. (Pubitemid 43379488)
5. Lo WY, Li JY, Chan YK, et al. Instability of clonality in gastric lymphoid infiltrates: a study with emphasis on serial biopsies. Am J Surg Pathol 2005;29:1582-1592. (Pubitemid 43754479)
6. de Mascarel A, Ruskone-Fourmestraux A, Lavergne-Slove A, Megraud F, Dubus P, Merlio JP. Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Arch 2005;446:219-224. (Pubitemid 40558375)
7. Fujimori K, Shimodaira S, Akamatsu T, Furihata K, Katsuyama T, Hosaka S. Effect of Helicobacter pylori eradication on ongoing mutation of immunoglobulin genes in gastric MALT lymphoma. Br J Cancer 2005;92:312-319.
8. Todorovic M, Balint B, Jevtic M, et al. Primary gastric mucosa associated lymphoid tissue lymphoma: clinical data predicted treatment outcome. World J Gastroenterol 2008;14:2388-2393. (Pubitemid 351877611)
9. Nakamura T, Seto M, Tajika M, et al. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Am J Gastroenterol 2008;103:62-70.
10. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 2007;56:1685-1687.
11. Joo M, Kwak JE, Chang SH, et al. Helicobacter heilmannii-associated gastritis: clinicopathologic findings and comparison with Helicobacter pylori-associated gastritis. J Korean Med Sci 2007;22:63-69.
12. Nakamura S, Matsumoto T, Ye H, et al. Helicobacter pylori- negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment. Cancer 2006;107:2770-2778.
13. Hong SS, Jung HY, Choi KD, et al. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Helicobacter 2006;11:569-573.
14. Wündisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005;23:8018-8024.
15. Chen LT, Lin JT, Tai JJ, et al. Long-term results of anti- Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst 2005;97:1345-1353.
16. Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004;53:34-37.
17. Kuo SH, Chen LT, Wu MS, et al. Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: need for a revisit of surgical treatment. Ann Surg 2008;247:265-269. (Pubitemid 351156768)
18. Martinelli G, Laszlo D, Ferreri AJ, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 2005;23:1979-1983. (Pubitemid 46211377)
19. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 1992;102:1628-1638.
20. Mueller A, O'Rourke J, Chu P, et al. Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A 2003;100:12289-12294. (Pubitemid 37271553)
21. Nakamura M, Murayama SY, Serizawa H, et al. "Candidatus Helicobacter heilmannii" from a cynomolgus monkey induces gastric mucosa-associated lymphoid tissue lymphomas in C57BL/6 mice. Infect Immun 2007;75:1214-1222.
22. Liu H, Ye H, Ruskone-Fourmestraux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002;122:1286-1294.
23. Nakagawa M, Seto M, Hosokawa Y. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein. Leukemia 2006;20:929-936.
24. Motegi M, Yonezumi M, Suzuki H, et al. API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 2000;156:807-812.
25. Hosokawa Y, Suzuki H, Suzuki Y, Takahashi R, Seto M. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma. Cancer Res 2004;64:3452-3457. (Pubitemid 38657917)
26. Inagaki H. Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance. Pathol Int 2007;57:474-484. (Pubitemid 47030131)
27. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999;96:35-45. (Pubitemid 29044151)
28. Zhang Q, Siebert R, Yan M, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14) (p22;q32). Nat Genet 1999;22:63-68. (Pubitemid 29214806)
29. Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 2001;276:19012-19019. (Pubitemid 37411225)
30. Liu H, Ye H, Dogan A, et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001;98:1182-1187.
31. Huynh MQ, Wacker HH, Wündisch T, et al. Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas. Leuk Lymphoma 2008;49:974-983. (Pubitemid 351942753)
32. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-866. (Pubitemid 44629897)
33. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838. (Pubitemid 40839735)
34. Suzuki H, Saito Y, Nishizawa T, et al. Overexpression of microRNA-142 and microRNA-155 in AP12-MALT1-positive gastric low-grade MALT lymphoma. Gastroenterology 2008;134:A61. (Abstract)
35. Saito Y, Suzuki H, Hibi T. The role of microRNAs in gastrointestinal cancers. J Gastroenterol 2009;44 Suppl 19:18-22.
36. Takino H, Okabe M, Li C, et al. p16/INK4a gene methyl ation is a frequent finding in pulmonary MALT lymphomas at diagnosis. Mod Pathol 2005;18:1187-1192. (Pubitemid 43079917)
37. Min KO, Seo EJ, Kwon HJ, et al. Methylation of p16 (INK4A) and p57(KIP2) are involved in the development and progression of gastric MALT lymphomas. Mod Pathol 2006;19:141-148. (Pubitemid 43250989)
38. Kaneko Y, Sakurai S, Hironaka M, et al. Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas. Gut 2003;52:641-646.